BACKGROUND: Chemerin is a recently discovered adipocytokine, associated with adiposity
and insulin sensitivity. The current study investigated the effects of lifestyle intervention on …

Objective Chemerin, a recently identified adipokine, has been linked to adiposity, insulin
resistance, metabolic syndrome risk factors and inflammation. Here, we evaluated whether a …

Background: Chemerin is a newly discovered adipokine, whose circulating concentration is
increased in obesity. Aim: To elucidate whether the increased circulating chemerin …

Chemerin is an adipokine that may mediate the link between obesity, inflammation, insulin
resistance, type 2 diabetes mellitus, and cardiovascular disease. In this study, we examined …

Recent data suggest that chemerin could be important for the pathophysiology of obesity.
However, its relation with clinical indices of obesity and metabolic parameters is …

OBJECTIVE: Chemerin is believed to be a mediator for the adipose tissue inflammation that
occurs in obesity. The present study compared chemerin levels between healthy and type 2 …

Objective Chemerin, a recently discovered adipocytokine, may be linked to obesity and
obesity‐associated metabolic complications. However, the relationship between visceral fat …

Objective Chemerin is a novel adipokine. Previous research has investigated the
association between chemerin and clinical indices in patients with obesity or metabolic …

Objective Chemerin has been suggested as a potential link between obesity and associated
comorbidities in humans. Therefore, we studied the relationships between chemerin …

Objective This study aimed to confirm existing assumptions about the associations of
circulating chemerin with inflammatory and metabolic parameters in a large population …